Quintiles Transnational Holdings Inc (Q.N)
Q.N on New York Stock Exchange
42.53USD
12:43pm EDT
42.53USD
12:43pm EDT
Price Change (% chg)
$-0.42 (-0.98%)
$-0.42 (-0.98%)
Prev Close
$42.95
$42.95
Open
$43.01
$43.01
Day's High
$43.33
$43.33
Day's Low
$42.53
$42.53
Volume
19,711
19,711
Avg. Vol
--
--
52-wk High
$46.40
$46.40
52-wk Low
$41.50
$41.50
About
Quintiles Transnational Holdings Inc. is a provider of biopharmaceutical development services and commercial outsourcing services. The Company operates in two segments: Product Development and Integrated Healthcare Services. The Company’s Product Development segment operates as a contract research organization (CRO) focused... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $5,689.50 |
| Shares Outstanding (Mil.): | 132.47 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| Q.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 34.45 | 32.18 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | -2.81 | 18.91 |
| ROE: | -- | -3.51 | 19.87 |
KKR funds to buy clinical trial firm PRA International
June 24 - Funds managed by KKR & Co LP will buy clinical research group PRA International from Genstar Capital LLC for an undisclosed amount, PRA said on Monday, underscoring growing private equity interest in the contract research industry.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Wright Reports
|
$437.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

